Benzinga | Nov 4, 2021 09:22AM EDT

Stephens & Co. Maintains Overweight on Steris, Raises Price Target to $270

Stephens & Co. analyst Chris Cooley maintains Steris (NYSE:STE) with a Overweight and raises the price target from $255 to $270.